Skip to content
GenoLensGenoLens

NAGLU

Chr 17q21.2

N-acetyl-alpha-glucosaminidase

Aliases:
NAG
MANE:
ENST00000225927.7

Annotations refreshed 1 month ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • DDG2P

    BIALLELIC, autosomal or pseudoautosomal
  • Intellectual disability

    BIALLELIC, autosomal or pseudoautosomal
  • Likely inborn error of metabolism

    BIALLELIC, autosomal or pseudoautosomal
  • Lysosomal storage disorder

    BIALLELIC, autosomal or pseudoautosomal
  • Mucopolysaccharideosis, Gaucher, Fabry

    BIALLELIC, autosomal or pseudoautosomal
  • Mucopolysaccharidosis type IIIB

    BIALLELIC, autosomal or pseudoautosomal
  • Skeletal dysplasia

    BIALLELIC, autosomal or pseudoautosomal
  • Undiagnosed metabolic disorders

    BIALLELIC, autosomal or pseudoautosomal

+12 more panels — install the extension to see the full list inline on any page.

Disease associations (Open Targets)

  • mucopolysaccharidosis type 3B

    0.87
  • Charcot-Marie-Tooth disease axonal type 2V

    0.73
  • mucopolysaccharidosis type 3

    0.72
  • hereditary disease

    0.53
  • Abnormality of metabolism/homeostasis

    0.45
  • Thick eyebrow

    0.43
  • Hepatosplenomegaly

    0.43
  • Abnormal facial shape

    0.43
  • hypertrichosis

    0.43
  • Coarse facial features

    0.43

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Alpha-N-acetylglucosaminidase

Involved in the degradation of heparan sulfate

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.